Controversies in the management of hyperphosphatemia in patients with end-stage renal disease.
Otoo
Andrew
A
Medical Affairs Department, Nabi Biopharmaceuticals, Rockville, MD, USA.
Little
Gregg
G
D000085:Acetates / Q000627:therapeutic use; D002114:Calcinosis / Q000503:physiopathology; D017610:Calcium Compounds; D002318:Cardiovascular Diseases; D002986:Clinical Trials as Topic; D003220:Conflict, Psychological; D019468:Disease Management; D006801:Humans; D007676:Kidney Failure, Chronic; D010710:Phosphates / Q000097:blood* / Q000378:metabolism; D016896:Treatment Outcome; D014481:United States
D000085:Acetates; D017610:Calcium Compounds; D010710:Phosphates; C120662:calcium acetate